The spinout of Yamaguchi University and National Cancer Centre Japan has raised the cash from investors including Dai-ichi Life and Binex.

The solid tumour therapy developer secured $21.9m from investors including Dai-ichi Life, Binex, Bigen and Shibuya Kogyo.

Samsung has promoted Dede Goldschmidt to run the vehicle, whose previous co-heads Shankar Chandran and Francis Ho have begun a new fund with its former chief strategy officer, Young Sohn.

The SIG-backed social network developer doubled its valuation to $250m in a round coming less than a year after it raised $35m.

The Tencent-backed online sports app operator’s latest secondary round valued it at nearly $5bn, though the identity of the sellers has not been disclosed.

The WuXi AppTec-backed infectious disease therapeutics developer has closed a series C round featuring various investment managers and Singapore's sovereign wealth fund.

The iFlytek-backed post-discharge care management platform received $23m in a round led by Sequoia Capital China.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SBI Investment will help manage the drug distributor’s Medipal Innovation Fund, which will invest in entrepreneurs in areas such as drug discovery and healthcare.

The DevSecOps software developer received $15m in a series A round led by Tencent and backed by existing investor Sequoia China.